Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells

被引:101
作者
Oike, Y
Ito, Y
Hamada, K
Zhang, XQ
Miyata, K
Arai, F
Inada, T
Araki, K
Nakagata, N
Takeya, M
Kisanuki, YY
Yanagisawa, M
Gale, NW
Suda, T
机构
[1] Kumamoto Univ, Dept Cell Differentiat, Kumamoto, Japan
[2] Kumamoto Univ, Dept Dev Genet, Kumamoto, Japan
[3] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto, Japan
[4] Kumamoto Univ, Anim Resource Ctr, Kumamoto, Japan
[5] Kumamoto Univ, Sch Med, Dept Pathol 2, Kumamoto 860, Japan
[6] Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX USA
[7] Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX USA
[8] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
关键词
D O I
10.1182/blood.V100.4.1326.h81602001326_1326_1333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although the cellular and molecular mechanisms governing angiogenesis are only beginning to be understood, signaling through endothelial-restricted receptors, particularly receptor tyrosine kinases, has been shown to play a pivotal role in these events. Recent reports show that EphB receptor tyrosine kinases and their transmembrane-type ephrin-B2 ligands play essential roles in the embryonic vasculature. These studies suggest that cell-to-cell repellent effects due to bidirectional EphB/ephrin-B2 signaling may be crucial for vascular development, similar to the mechanism described for neuronal development. To test this hypothesis, we disrupted the precise expression pattern of EphB/ephrin-B2 In vivo by generating transgenic (CAGp-ephrin-B2 Tg) mice that express ephrin-B2 under the control of a ubiquitous and constitutive promoter, CMV enhancer-beta-actin promoter-beta-globin splicing acceptor (CAG). These mice displayed an abnormal segmental arrangement of Intersomitic vessels, while such anomalies were not observed in Tie-2p-ephrin-82 Tg mice in which ephrin-B2 was overexpressed In only vascular endothelial cells (ECs). This finding suggests that non-ECs expressing ephrin-B2 alter the migration of ECs expressing EphB receptors Into the intersomitic region where ephrin-B2 expression is normally absent. CAGpephrin-B2 Tg mice show sudden death at neonatal stages from aortic dissecting aneurysms due to defective recruitment of vascular smooth muscle cells to the ascending aorta. EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells plays an essential role in vasculogenesis, angiogenesis, and vessel maturation. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:1326 / 1333
页数:8
相关论文
共 42 条
[1]   The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration [J].
Adams, RH ;
Diella, F ;
Hennig, S ;
Helmbacher, F ;
Deutsch, U ;
Klein, R .
CELL, 2001, 104 (01) :57-69
[2]   Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].
Adams, RH ;
Wilkinson, GA ;
Weiss, C ;
Diella, F ;
Gale, NW ;
Deutsch, U ;
Risau, W ;
Klein, R .
GENES & DEVELOPMENT, 1999, 13 (03) :295-306
[3]  
[Anonymous], 1994, MANIPULATING MOUSE E
[4]  
Araki K, 1997, J BIOCHEM, V122, P977, DOI 10.1093/oxfordjournals.jbchem.a021860
[5]   Targeted integration of DNA using mutant lox sites in embryonic stem cells [J].
Araki, K ;
Araki, M ;
Yamamura, KI .
NUCLEIC ACIDS RESEARCH, 1997, 25 (04) :868-872
[6]   Tyrosine phosphorylation of transmembrane ligands for Eph receptors [J].
Bruckner, K ;
Pasquale, EB ;
Klein, R .
SCIENCE, 1997, 275 (5306) :1640-1643
[7]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[8]   LIGANDS FOR EPH-RELATED RECEPTOR TYROSINE KINASES THAT REQUIRE MEMBRANE ATTACHMENT OR CLUSTERING FOR ACTIVITY [J].
DAVIS, S ;
GALE, NW ;
ALDRICH, TH ;
MAISONPIERRE, PC ;
LHOTAK, V ;
PAWSON, T ;
GOLDFARB, M ;
YANCOPOULOS, GD .
SCIENCE, 1994, 266 (5186) :816-819
[9]  
DUMONT DJ, 1992, ONCOGENE, V7, P1471
[10]   Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442